Literature DB >> 7582098

Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo.

M Jung1, E Krämer, M Grzenkowski, K Tang, W Blakemore, A Aguzzi, K Khazaie, K Chlichlia, G von Blankenfeld, H Kettenmann.   

Abstract

Replication-defective retroviruses expressing the t-neu oncogene, or a hybrid protein with the neu tyrosine kinase linked to the external region of the human epidermal growth factor receptor (egfr-neu), were used to establish lines of murine oligodendroglial precursor cells. Differentiation of the t-neu lines into myelin-associated glycoprotein (MAG)-positive oligodendrocytes was induced by dibutyryl cAMP, and the egfr-neu line showed limited differentiation in vitro upon withdrawal of epidermal growth factor. Cerebellar granule cell neurons expressed mitogens for the cell lines. Upon transplantation into demyelinated lesions, t-neu line cells engaged with the demyelinated axons whereas the egfr-neu line cells differentiated further and ensheathed the axons. These cell lines thus interact with neurons in vitro and in vivo and can be used as tools to define the molecules involved in different stages of neuron-glia interaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582098     DOI: 10.1111/j.1460-9568.1995.tb01115.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  102 in total

1.  Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration.

Authors:  A Niehaus; J Stegmüller; M Diers-Fenger; J Trotter
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  The major myelin-resident protein PLP is transported to myelin membranes via a transcytotic mechanism: involvement of sulfatide.

Authors:  Wia Baron; Hande Ozgen; Bert Klunder; Jenny C de Jonge; Anita Nomden; Annechien Plat; Elisabeth Trifilieff; Hans de Vries; Dick Hoekstra
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

3.  Plasticity of the myelination genomic fabric.

Authors:  Sanda Iacobas; Neil M Thomas; Dumitru A Iacobas
Journal:  Mol Genet Genomics       Date:  2012-01-13       Impact factor: 3.291

Review 4.  NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction.

Authors:  Khalad Karram; Nivedita Chatterjee; Jacqueline Trotter
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

5.  A molecular insight of Hes5-dependent inhibition of myelin gene expression: old partners and new players.

Authors:  Aixiao Liu; Jiadong Li; Mireya Marin-Husstege; Ryochiro Kageyama; Yongjun Fan; Celine Gelinas; Patrizia Casaccia-Bonnefil
Journal:  EMBO J       Date:  2006-09-28       Impact factor: 11.598

6.  Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation.

Authors:  Eva Herrero-Herranz; Luis A Pardo; Gertrude Bunt; Ralf Gold; Walter Stühmer; Ralf A Linker
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

7.  Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.

Authors:  Joshua E Burda; Maja Radulovic; Hyesook Yoon; Isobel A Scarisbrick
Journal:  Glia       Date:  2013-07-08       Impact factor: 7.452

8.  Misalignment of PLP/DM20 transmembrane domains determines protein misfolding in Pelizaeus-Merzbacher disease.

Authors:  Ajit Singh Dhaunchak; David R Colman; Klaus-Armin Nave
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

9.  Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation.

Authors:  Joseph J Abrajano; Irfan A Qureshi; Solen Gokhan; Deyou Zheng; Aviv Bergman; Mark F Mehler
Journal:  PLoS One       Date:  2009-11-03       Impact factor: 3.240

10.  Actomyosin contractility controls cell surface area of oligodendrocytes.

Authors:  Angelika Kippert; Dirk Fitzner; Jonne Helenius; Mikael Simons
Journal:  BMC Cell Biol       Date:  2009-09-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.